Cargando…
Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy
First-line immunotherapy in non-small-cell lung cancer largely improved patients’ survival. PD-L1 testing is required before immune checkpoint inhibitor initiation. However, this biomarker fails to accurately predict patients’ response. On the other hand, immunotherapy exposes patients to immune-rel...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9974692/ https://www.ncbi.nlm.nih.gov/pubmed/36414693 http://dx.doi.org/10.1007/s00281-022-00973-1 |